AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million shares as investors ...

Observational analyses can complement randomized clinical trial findings for the study of HPV vaccine effectiveness

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
European Medical Journal

EAU 2026: Patient Preferences in Prostate Cancer Treatment Decisions

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer

Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.
GitHub

Erasmus MC Genomics Core Facility

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Open Access Government

How can research benefit children of parents with severe mental illness?

The FAMILY consortium, an EU-funded study, aims to understand the intergenerational transmission of mental illness risk ...
GitHub

Intel, AMD, VIA & Freescale Microcode Extraction Tool

MC Extractor is a tool which parses Intel, AMD, VIA and Freescale processor microcode binaries. It can be used by end-users who are looking for all relevant microcode information such as CPUID, ...
ESPN Cricinfo

Best career bowling average in T20s

Abbottabad Region v Lahore Region Whites at Peshawar, National T20 Cup 2nd semi final, Mar 17, 2026 [Twenty20] Karachi Region Whites v Sialkot Region at Peshawar, National T20 Cup 1st semi final, Mar ...